- Home
- BNT vs SNN Comparison
BNT vs SNN Comparison
Compare BNT & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNT
- SNN
- Stock Information
- Founded
- BNT 2020
- SNN 1856
- Country
- BNT Bermuda
- SNN United Kingdom
- Employees
- BNT N/A
- SNN N/A
- Industry
- BNT
- SNN Industrial Specialties
- Sector
- BNT
- SNN Health Care
- Exchange
- BNT Nasdaq
- SNN Nasdaq
- Market Cap
- BNT 14.4B
- SNN 12.7B
- IPO Year
- BNT N/A
- SNN 1999
- Fundamental
- Price
- BNT $59.64
- SNN $28.55
- Analyst Decision
- BNT
- SNN Hold
- Analyst Count
- BNT 0
- SNN 3
- Target Price
- BNT N/A
- SNN $27.50
- AVG Volume (30 Days)
- BNT 10.2K
- SNN 750.0K
- Earning Date
- BNT 08-07-2025
- SNN 07-31-2025
- Dividend Yield
- BNT 0.57%
- SNN 2.62%
- EPS Growth
- BNT N/A
- SNN 56.15
- EPS
- BNT 2.28
- SNN 0.47
- Revenue
- BNT $14,236,000,000.00
- SNN $5,810,000,000.00
- Revenue This Year
- BNT N/A
- SNN $6.87
- Revenue Next Year
- BNT N/A
- SNN $5.19
- P/E Ratio
- BNT $26.09
- SNN $30.62
- Revenue Growth
- BNT 73.14
- SNN 4.70
- 52 Week Low
- BNT $40.12
- SNN $23.69
- 52 Week High
- BNT $62.72
- SNN $31.72
- Technical
- Relative Strength Index (RSI)
- BNT N/A
- SNN 43.65
- Support Level
- BNT N/A
- SNN $29.84
- Resistance Level
- BNT N/A
- SNN $30.38
- Average True Range (ATR)
- BNT 0.00
- SNN 0.36
- MACD
- BNT 0.00
- SNN -0.18
- Stochastic Oscillator
- BNT 0.00
- SNN 7.50
About BNT Brookfield Wealth Solutions Ltd.
Brookfield Wealth Solutions Ltd, formerly Brookfield Reinsurance Ltd operates a capital solutions business providing insurance and reinsurance services to individuals and institutions. Through its subsidiary, the company offers a broad range of insurance products and services, including life insurance and annuities, and personal and commercial property and casualty insurance. It is organized into three reporting segments: Direct Insurance, Reinsurance, and Pension Risk Transfer (PRT).
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.